Q2 2026 Holdings
Filed 2026-08-14 | 9 holdings | $362.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alumis Inc.(ALMS) | COM | 022307102 | $165.9M | 5,896,995 | 45.8% |
| CG Oncology, Inc.(CGON) | COM | 156944100 | $76.7M | 1,079,050 | 21.2% |
| Disc Medicine, Inc.(IRON) | COM | 254604101 | $27.4M | 374,069 | 7.6% |
| Hims & Hers Health, Inc.(HIMS) | COM CL A | 433000106 | $25.6M | 738,151 | 7.1% |
| Pharvaris N.V.(PHVS) | COM | N69605108 | $23.0M | 664,142 | 6.3% |
| Eikon Therapeutics, Inc.(EIKN) | COM | 282564103 | $17.2M | 1,318,983 | 4.8% |
| Odyssey Therapeutics, Inc.(ODTX) | COM | 67613T104 | $13.3M | 713,105 | 3.7% |
| Lyell Immunopharma, Inc.(LYEL) | COM | 55083R203 | $6.7M | 476,386 | 1.8% |
| Nurix Therapeutics, Inc.(NRIX) | COM | 67080M103 | $6.4M | 265,000 | 1.8% |